Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Aug;67(790):707–709. doi: 10.1136/pgmj.67.790.707

Current views on aetiology and management of haemolytic uraemic syndrome.

M M Fitzpatrick 1, M J Dillon 1
PMCID: PMC2399050  PMID: 1754520

Full text

PDF
707

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aster R. H. Plasma therapy for thrombotic thrombocytopenic purpura. Sometimes it works, but why? N Engl J Med. 1985 Apr 11;312(15):985–987. doi: 10.1056/NEJM198504113121510. [DOI] [PubMed] [Google Scholar]
  2. Binda ki Muaka P., Proesmans W., Eeckels R. The haemolytic uraemic syndrome in childhood: a study of the long-term prognosis. Eur J Pediatr. 1981 Jul;136(3):237–243. doi: 10.1007/BF00442990. [DOI] [PubMed] [Google Scholar]
  3. Carter A. O., Borczyk A. A., Carlson J. A., Harvey B., Hockin J. C., Karmali M. A., Krishnan C., Korn D. A., Lior H. A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med. 1987 Dec 10;317(24):1496–1500. doi: 10.1056/NEJM198712103172403. [DOI] [PubMed] [Google Scholar]
  4. Cattell V. Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat. Am J Pathol. 1985 Oct;121(1):88–95. [PMC free article] [PubMed] [Google Scholar]
  5. Chart H., Smith H. R., Scotland S. M., Rowe B., Milford D. V., Taylor C. M. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet. 1991 Jan 19;337(8734):138–140. doi: 10.1016/0140-6736(91)90801-u. [DOI] [PubMed] [Google Scholar]
  6. Donohue-Rolfe A., Keusch G. T., Edson C., Thorley-Lawson D., Jacewicz M. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. J Exp Med. 1984 Dec 1;160(6):1767–1781. doi: 10.1084/jem.160.6.1767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drummond K. N. Hemolytic uremic syndrome--then and now. N Engl J Med. 1985 Jan 10;312(2):116–118. doi: 10.1056/NEJM198501103120211. [DOI] [PubMed] [Google Scholar]
  8. Fong J. S., de Chadarevian J. P., Kaplan B. S. Hemolytic-uremic syndrome. Current concepts and management. Pediatr Clin North Am. 1982 Aug;29(4):835–856. doi: 10.1016/s0031-3955(16)34216-x. [DOI] [PubMed] [Google Scholar]
  9. Garibotto G., Acquarone N., Saffioti S., Deferrari G., Villaggio B., Ferrario F. Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis. Nephron. 1989;51(3):409–412. doi: 10.1159/000185333. [DOI] [PubMed] [Google Scholar]
  10. Kaplan B. S., Chesney R. W., Drummond K. N. Hemolytic uremic syndrome in families. N Engl J Med. 1975 May 22;292(21):1090–1093. doi: 10.1056/NEJM197505222922102. [DOI] [PubMed] [Google Scholar]
  11. Kaplan B. S. Hemolytic uremic syndrome with recurrent episodes: an important subset. Clin Nephrol. 1977 Dec;8(6):495–498. [PubMed] [Google Scholar]
  12. Kaplan B. S., Proesmans W. The hemolytic uremic syndrome of childhood and its variants. Semin Hematol. 1987 Jul;24(3):148–160. [PubMed] [Google Scholar]
  13. Karmali M. A., Petric M., Lim C., Fleming P. C., Arbus G. S., Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985 May;151(5):775–782. doi: 10.1093/infdis/151.5.775. [DOI] [PubMed] [Google Scholar]
  14. Karmali M. A., Steele B. T., Petric M., Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983 Mar 19;1(8325):619–620. doi: 10.1016/s0140-6736(83)91795-6. [DOI] [PubMed] [Google Scholar]
  15. Kavi J., Chant I., Maris M., Rose P. E. Cytopathic effect of verotoxin on endothelial cells. Lancet. 1987 Oct 31;2(8566):1035–1035. doi: 10.1016/s0140-6736(87)92609-2. [DOI] [PubMed] [Google Scholar]
  16. Kleanthous H., Smith H. R., Scotland S. M., Gross R. J., Rowe B., Taylor C. M., Milford D. V. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child. 1990 Jul;65(7):722–727. doi: 10.1136/adc.65.7.722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Levin M., Barratt J. M. Haemolytic uraemic syndrome. Arch Dis Child. 1984 May;59(5):397–400. doi: 10.1136/adc.59.5.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lingwood C. A., Law H., Richardson S., Petric M., Brunton J. L., De Grandis S., Karmali M. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem. 1987 Jun 25;262(18):8834–8839. [PubMed] [Google Scholar]
  19. Loirat C., Sonsino E., Hinglais N., Jais J. P., Landais P., Fermanian J. Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol. 1988 Jul;2(3):279–285. doi: 10.1007/BF00858677. [DOI] [PubMed] [Google Scholar]
  20. Moorthy B., Makker S. P. Hemolytic-uremic syndrome associated with pneumococcal sepsis. J Pediatr. 1979 Oct;95(4):558–559. doi: 10.1016/s0022-3476(79)80765-9. [DOI] [PubMed] [Google Scholar]
  21. Novak R. W., Martin C. R., Orsini E. N. Hemolytic-uremic syndrome and T-cryptantigen exposure by neuraminidase-producing pneumococci: an emerging problem? Pediatr Pathol. 1983 Oct-Dec;1(4):409–413. doi: 10.3109/15513818309025872. [DOI] [PubMed] [Google Scholar]
  22. O'Brien A. D., Holmes R. K. Shiga and Shiga-like toxins. Microbiol Rev. 1987 Jun;51(2):206–220. doi: 10.1128/mr.51.2.206-220.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. O'Brien A. D., Holmes R. K. Shiga and Shiga-like toxins. Microbiol Rev. 1987 Jun;51(2):206–220. doi: 10.1128/mr.51.2.206-220.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Obrig T. G., Del Vecchio P. J., Karmali M. A., Petric M., Moran T. P., Judge T. K. Pathogenesis of haemolytic uraemic syndrome. Lancet. 1987 Sep 19;2(8560):687–687. doi: 10.1016/s0140-6736(87)92473-1. [DOI] [PubMed] [Google Scholar]
  25. Rabadi S. J., Khandekar J. D., Miller H. J. Mitomycin-induced hemolytic uremic syndrome: case presentation and review of literature. Cancer Treat Rep. 1982 May;66(5):1244–1247. [PubMed] [Google Scholar]
  26. Rizzoni G., Claris-Appiani A., Edefonti A., Facchin P., Franchini F., Gusmano R., Imbasciati E., Pavanello L., Perfumo F., Remuzzi G. Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial. J Pediatr. 1988 Feb;112(2):284–290. doi: 10.1016/s0022-3476(88)80071-4. [DOI] [PubMed] [Google Scholar]
  27. Scotland S. M., Smith H. R., Rowe B. Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet. 1985 Oct 19;2(8460):885–886. doi: 10.1016/s0140-6736(85)90146-1. [DOI] [PubMed] [Google Scholar]
  28. Seges R. A., Kenny A., Bird G. W., Wingham J., Baals H., Stauffer U. G. Pediatric surgical patients with severe anaerobic infection: report of 16 T-antigen positive cases and possible hazards of blood transfusion. J Pediatr Surg. 1981 Dec;16(6):905–910. doi: 10.1016/s0022-3468(81)80844-5. [DOI] [PubMed] [Google Scholar]
  29. Sheth K. J., Leichter H. E., Gill J. C., Baumgardt A. Reversal of central nervous system involvement in hemolytic uremic syndrome by use of plasma exchanges. Clin Pediatr (Phila) 1987 Dec;26(12):651–656. doi: 10.1177/000992288702601208. [DOI] [PubMed] [Google Scholar]
  30. Sheth K. J., Swick H. M., Haworth N. Neurological involvement in hemolytic-uremic syndrome. Ann Neurol. 1986 Jan;19(1):90–93. doi: 10.1002/ana.410190120. [DOI] [PubMed] [Google Scholar]
  31. Trompeter R. S., Schwartz R., Chantler C., Dillon M. J., Haycock G. B., Kay R., Barratt T. M. Haemolytic-uraemic syndrome: an analysis of prognostic features. Arch Dis Child. 1983 Feb;58(2):101–105. doi: 10.1136/adc.58.2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Upadhyaya K., Barwick K., Fishaut M., Kashgarian M., Siegel N. J. The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics. 1980 Jan;65(1):115–120. [PubMed] [Google Scholar]
  33. Walters M. D., Matthei I. U., Kay R., Dillon M. J., Barratt T. M. The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol. 1989 Apr;3(2):130–134. doi: 10.1007/BF00852893. [DOI] [PubMed] [Google Scholar]
  34. White D. J., Yong F., McKendrick M. W. Haemolytic uraemic syndrome in adults. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):899–899. doi: 10.1136/bmj.296.6626.899. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES